Seegene, Inc., headquartered in Seoul, South Korea, specializes in advanced nucleic acid detection technologies. The company focuses on developing innovative diagnostic solutions that leverage oligonucleotide amplification and signal differentiation techniques. Seegene's expertise includes the use of magnetic beads and fluorescence for enhanced detection accuracy. Their cutting-edge technologies are pivotal in the fields of molecular diagnostics, enabling rapid and reliable testing for various infectious diseases and genetic conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

69 Patents

#104 in Seoul

#252 in South Korea

#10,763 in the World

Seoul, South Korea

Seegene, Inc.

Forward Citations = 96

53 inventors:

Jong Yoon Chun (36 out of 36 patents)

Young Jo Lee (31 out of 97 patents)

Jong-Yoon Chun (7 out of 8 patents)

4. Young Wook Kim (7 out of 37 patents)

5. Han Bit Lee (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Seegene, Inc.. Retrieved from https://idiyas.com/company/seegene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

54 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]